Atossa Therapeutics ATOS
NASDAQ ATOS
$2.03 -0.11 (-5.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Atossa Therapeutics (ATOS) Cash from Discontinued Operations (2015)

Updated

Atossa Therapeutics (ATOS) reported Cash from Discontinued Operations of -$2.91 million for Q4 2015.

Analysis

Atossa Therapeutics (ATOS) Cash from Discontinued Operations (2015) Analysis & Trends

For FY2015, Atossa Therapeutics posted Cash from Discontinued Operations of -$2.63 million.

  • By year, Cash from Discontinued Operations came in at -$2.09 million in FY2014.
  • Per Business Quant data, the three quarters before Q4 2015 came in at $82,891 (Q3 2015), $682,458 (Q2 2015) and -$493,005 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Atossa Therapeutics 21.38 Mn -98.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 2.37 Mn
Sep 30, 2015 544,802.00
Jun 30, 2015 23,438.00
Mar 31, 2015 -493,005.00
API Access

Atossa Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ATOS&period=max&api_key=YOUR_API_KEY